Patent details

EN | LT

LT - 1,2,4-Triazolo[4,3-a]piridino junginiai ir jų panaudojimas kaip MGLUR2 receptorių alosterinių moduliatorių

EN - 1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

Legal status

Patent in force

Claims | Licences/Sublicenses

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 471/04	(2006.01)
		A61K 31/437	(2006.01)

European patent
(11)	Number of the document	3041839
(13)	Kind of document	T
(96)	European patent application number	14758564.0
	Date of filing the European patent application	2014-09-03
(97)	Date of publication of the European application	2016-07-13
(45)	Date of publication and mention of the grant of the patent	2017-07-26
(46)	Date of publication of the claims translation	2017-09-25

PCT application
(86)	Number	PCT/EP2014/068676
	Date	2014-09-03

PCT application publication
(87)	Number	WO 2015/032790
	Date	2015-03-12

Inventors
(72)	CID-N ŃEZ, José, Maria, ES TRABANCO-SU REZ, Andrés, Avelino, ES LAVREYSEN, Hilde, BE CEUSTERS, Marc André, BE

Grantee
(73)	Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, BE

Attorney or representative
(74)	Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT

Title
(54)	1,2,4-Triazolo[4,3-a]piridino junginiai ir jų panaudojimas kaip MGLUR2 receptorių alosterinių moduliatorių
	1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

Last renewal fee
	Payment date	Validity (years)	Amount
	2025-08-04	12	289.00 EUR

Next renewal fee
	2026-09-03